New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 9, 2012
10:29 EDTVECO, SMG, FOSL, DMD, AIG, PRTS, UA, MGLN, EZPW, CPE, HSY, STJ, IQNT, DOW, AFFXOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AIG (AIG) upgraded to Buy from Neutral at Goldman... Affymetrix (AFFX) upgraded to Equal Weight from Underweight at Morgan Stanley... Callon Petroleum (CPE) upgraded to Outperform from Neutral at RW Baird... Demand Media (DMD) upgraded to Buy from Neutral at Citigroup... Dow Chemical (DOW) upgraded to Overweight from Equal Weight at Morgan Stanley... EZCORP (EZPW) upgraded to Neutral from Underperform at Sterne Agee... Fossil (FOSL) upgraded to Buy from Hold at Benchmark Co... Inteliquent (IQNT) upgraded to Outperform from Neutral at RW Baird... Magellan Health (MGLN) upgraded to Buy from Neutral at BofA/Merrill... Scotts Miracle-Gro (SMG) upgraded to Market Perform from Underperform at BMO Capital... St. Jude Medical (STJ) upgraded to Overweight from Equal Weight at Morgan Stanley... Under Armour (UA) upgraded to Buy from Neutral at UBS... Veeco (VECO) upgraded to Overweight from Neutral at Piper Jaffray... Hershey (HSY) upgraded to Buy from Hold at Argus... U.S. Auto Parts (PRTS) upgraded to Buy from Neutral at Roth Capital.
News For AIG;AFFX;CPE;DMD;DOW;EZPW;FOSL;IQNT;MGLN;SMG;STJ;UA;VECO;HSY;PRTS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 27, 2015
10:00 EDTAFFXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:26 EDTSTJOn The Fly: Pre-market Movers
Subscribe for More Information
08:08 EDTDOWDow AgroSciences, ICS-CAAS partner to accelerate rice research in China
Dow AgroSciences, a wholly owned subsidiary of Dow Chemical, has entered into a collaboration agreement with the Institute of Crop Sciences of the Chinese Academy of Agricultural Sciences, or ICS-CAAS. Under the agreement, Dow AgroSciences grants ICS-CAAS a royalty-free, non-transferable research and commercialization license for its proprietary EXZACT Precision Genome Editing Technology to be used in rice in China. Dow AgroSciences and ICS-CAAS scientists will collaboratively develop an industry-leading rice genome editing technology platform. The EXZACT Precision Genome Editing Platform will enable ICS-CAAS scientists to capitalize on their significant investment and technical expertise in rice genomics, transcriptomics, proteomics, and cell biology as well as accelerate integration of the scientific knowledge generated in rice to rapidly develop valuable products for China. Dow AgroSciences has developed the EXZACT Precision Technology platform under an exclusive license and collaboration agreement in plants with Sangamo BioSciences, Inc. Dow AgroSciences and ICS-CAAS scientists will work together to make sure that the expertise and strengths of both parties are best combined to accelerate rice research and product development in China. This is part of Dow AgroSciences' commitment to providing innovative and sustainable solutions to bolster food security and food safety in China.
07:57 EDTSTJAbbott spokesman says company not making offer for St. Jude, Bloomberg reports
The spokesperson's statement to Bloomberg follows a report earlier this morning from Financial Times that claimed Abbott (ABT) is prepping a takeover offer for St. Jude Medical (STJ) that would value the latter at $25B.
07:51 EDTSTJThoratec volatility low into report Abbott prepping offer for St. Jude Medical
Thoratec (THOR) September call option implied volatility is at 10, October is at 6; compared to its 52-week range of 8 to 54 suggesting decreasing price movement into reports Abbott (ABT) is preparing a bid for St. Jude Medical (STJ). In July St. Jude Medical and Thoratec approved an agreement under which St. Jude Medical will acquire all of the outstanding shares of Thoratec for $63.50 per share in a cash. The deal is scheduled to close in Q4.
07:45 EDTSTJAbbott volatility up into report prepping takeover offer for St. Jude Medical
Subscribe for More Information
07:39 EDTSTJSt. Jude Medical volatility up, Abbott prepping $25B takeover offer FT reports
St. Jude Medical (STJ) September call option implied volatility is at 29, October is at 27; compared to its 52-week range of 17 to 36; suggesting slightly larger near term price movement into Abbott (ABT) is prepping a takeover offer that would value the company at $25B, sources tell The Financial Times.
06:57 EDTSTJAbbott prepping $25B takeover offer for St. Jude Medical, FT reports
Subscribe for More Information
06:56 EDTSTJAbbott prepping $25B takeover offer for St. Jude Medical, FT reports
Subscribe for More Information
August 26, 2015
16:10 EDTAFFXAffymetrix initiated with a Buy at Cantor
Subscribe for More Information
11:43 EDTUAUnder Armour investors approve plan for Class C shares, Bloomberg reports
Subscribe for More Information
10:26 EDTUAUnder Armour investors approve plan for Class C shares, Bloomberg reports
Bloomberg cites an e-mail confirmation from a company spokesperson.
August 25, 2015
07:54 EDTSTJSt. Jude Medical management to meet with Oppenheimer
Subscribe for More Information
August 24, 2015
09:49 EDTFOSLFitbit being sold at Macy's seen as near-term catalyst
Subscribe for More Information
08:31 EDTSTJSt. Jude Medical receives CE Mark for MRI labeling for Prodigy MRI system
Subscribe for More Information
August 21, 2015
15:51 EDTUAUnder Armour to host special shareholder meeting
Subscribe for More Information
08:50 EDTSTJThoratec announces end of 'go shop' period in merger agreement with St. Jude
Subscribe for More Information
August 20, 2015
11:54 EDTIQNTInteliquent upgraded to Strong Buy from Buy at BWS Financial
Subscribe for More Information
10:00 EDTFOSLOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:55 EDTFOSLFossil upgraded to Sector Weight from Underweight at KeyBanc
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use